NFKB1 and systemic inflammatory response syndrome: We found that SIRS-induced activation of NF-κB in both MLNs and ileum mucosa was reversed by pretreatment with CO in a dose-dependent manner with statistical significance at doses of 13 and 26 mg/kg (Fig. 2).